⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis

Official Title: A Long-Term, Single-Arm, Open-label, Multicenter Phase 3 Study to Evaluate the Safety and Tolerability of Multiple Subcutaneous Injections of Efgartigimod PH20 SC in Patients With Generalized Myasthenia Gravis

Study ID: NCT04818671

Study Description

Brief Summary: The purpose of this study is to evaluate the long-term safety and tolerability of efgartigimod PH20 SC 1000 mg, and the clinical efficacy, PD, pharmacokinetics (PK), immunogenicity, impact on the quality of life (QoL) of the participants, treatment satisfaction, and administration method preference, and the feasibility of self- and caregiver-supported administration of the SC injection. Treatment duration: 3-week treatment periods, repeated as needed with at least 28 days in between treatment periods Health measurements: total levels of immunoglobulin G (IgG), Acetylcholine receptor binding autoantibodies (AChR-Ab) levels, Myasthenia Gravis Activities of Daly Living (MG-ADL).

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Investigator site 6 - US0010032, Carlsbad, California, United States

Investigator Site 47 - US0010021, Palo Alto, California, United States

Investigator Site 45 - US0010108, Boca Raton, Florida, United States

Investigator site 4 - US0010110, Port Charlotte, Florida, United States

Investigator Site 39 - US0010006, Tampa, Florida, United States

Investigator Site 41 - US0010015, Kansas City, Kansas, United States

Investigator Site 46 - US0010111, Amherst, New York, United States

Investigator Site 38 - US0010003, Chapel Hill, North Carolina, United States

Investigator Site 44 - US0010077, Durham, North Carolina, United States

Investigator Site 42 - US0010019, Cleveland, Ohio, United States

Investigator site 7 - US0010008, Cordova, Tennessee, United States

Investigator Site 43 - US0010066, Austin, Texas, United States

Investigator Site 40 - US0010009, San Antonio, Texas, United States

Investigator site 5 - BE0320007, Gent, , Belgium

Investigator site 24 - CZ4200005, Brno, , Czechia

Investigator site 2 - GEO9950002, Tbilisi, , Georgia

Investigator Site 1 - GEO9950001, Tbilisi, , Georgia

Investigator site 3 - GEO9950003, Tbilisi, , Georgia

Investigator Site 32 - GEO9950004, Tbilisi, , Georgia

Investigator Site 33 - GEO9950016, Tbilisi, , Georgia

Investigator Site 25 - DE490006, Berlin, , Germany

Investigator Site 26 - DE490009, Münster, , Germany

Investigator site 10 - HU0360013, Budapest, , Hungary

Investigator site 9 - HU0360012, Budapest, , Hungary

Investigator site 11 - IT0390003, Milano, , Italy

Investigator Site 34 - IT0390007, Napoli, , Italy

Investigator Site 35 - IT0390008, Roma, , Italy

Investigator site 12 - JP0810002, Chiba, Chiba-Shi, Japan

Investigator Site 36 - JP0810055, Sapporo, Hokkaido, Japan

Investigator site 8 - JP0810004, Hanamaki, Iwate, Japan

Investigator Site 28- JP0810059, Ota-Ku, Tokyo, Japan

Investigator site 14 - JP0810007, Osaka, , Japan

Investigator Site 27 - JP0810008, Sapporo, , Japan

Investigator site 13 - JP0810005, Sendai-shi, , Japan

Investigator site 15 - JP0810009, Tokyo, , Japan

Investigator site 16 - NL0310001, Leiden, , Netherlands

Investigator site 17 - PL0480001, Gdańsk, , Poland

Investigator site 19 - PL0480007, Katowice, , Poland

Investigator site 22 - PL0480065, Kraków, , Poland

Investigator site 18 - PL0480005, Kraków, , Poland

Investigator site 20 - PL0480018, Lublin, , Poland

Investigator site 21 - PL0480022, Warsaw, , Poland

Investigator Site 29- RU0070002, Novosibirsk, , Russian Federation

Investigator Site 30 - RU0070014, Saint Petersburg, , Russian Federation

Investigator Site 37 - ES0340021, Barcelona, , Spain

Investigator Site 31 - ES0340038, Barcelona, , Spain

Investigator site 23 - ES0340039, Valencia, , Spain

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: